|

ACT001 Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since August 2026

Pipeline

Phase 2: 2

Top Sponsors

  • Nationwide Children's Hospital1
  • National Neuroscience Institute1

Indications

  • Cancer2
  • H3K27-altered High Grade Glioma1
  • Recurrent DIPG1
  • Refractory DIPG1
  • Progressive DIPG1

Other1 trial

Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature
Phase 2

Aurora, Colorado1 trial

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Children's Hospital Colorado

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.